What does impairment of intangible assets mean?

The recognized loss in the carrying value of finite-lived intangible assets when their book value exceeds their recoverable amount. This metric signals potential overvaluation of assets or a decline in the expected future economic benefits of intellectual property or licenses. It is a critical indicator of asset quality and long-term strategic viability.

Achieve Life Sciences ACHV Impairment of intangible assets

Impairment of intangible assets at other companies

Grid Dynamics Holdings, Inc.GDYN

$0—

American Healthcare REITAHR

$0—

Accel EntertainmentACEL

$0-100%

CarGurus, Inc.CARG

$1.65M-13.2%

Albany International Inc.AIN

$300K—

Achieve Life SciencesACHV

$0—

Other financials

Income statement

See full

Net income-$10.2M+20.7%

EPS (diluted)-$0.19+48.6%

Balance sheet

See full

Cash & equivalents$28.1M+116%

Total debt$5.6M+332%

Total equity$10.7M+3.9%

Total assets$33.1M+21.0%

Cash flow

See full

Operating cash flow-$6.9M+37.5%

CapEx$750.0—

Free cash flow-$12.4M—

Valuation

See full

Market cap$585.16M+404%

Enterprise value$562.71M+439%

Returns & leverage

See full

Return on equity-496.1%-906pp

Debt / equity0.5×+0.4×

Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's impairment of intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Achieve Life Sciences's impairment of intangible assets?: Achieve Life Sciences (ACHV) reported impairment of intangible assets of $0 in Q1 2026.
What does impairment of intangible assets mean?: The recognized loss in the carrying value of finite-lived intangible assets when their book value exceeds their recoverable amount. This metric signals potential overvaluation of assets or a decline in the expected future economic benefits of intellectual property or licenses. It is a critical indicator of asset quality and long-term strategic viability.